Lipids are important energy-dense macronutrients that are efficiently utilised by most fish species and, consequently, there is a tendency to use high-fat diets (HFD) in intensive aquaculture due to the protein-sparing and growth-promoting effects of dietary lipid(Reference Du, Liu and Tian1,Reference Li, Jiang and Liu2) . However, HFD commonly cause excess fat accumulation in liver or visceral fat tissue in farmed fish, leading to liver injury and lipid metabolism disorders(Reference Cao, Dai and Liu3–Reference Nath, Matozzo and Bhandari8). Similar results have been reported in mammals, indicating that excess dietary fat can cause injury in the liver and various other tissues and organs(Reference Aloui, Charradi and Hichami9–Reference Mahmoudi, Charradi and Limam13). HFD-induced obesity in rodents has shown conclusively that hepatic steatosis is associated with a state of chronic hepatic inflammation(Reference Day14). Recently, studies demonstrated that HFD could impair lipid homoeostasis and induce inflammatory responses in several marine fish species, including black seabream (Acanthopagrus schlegelii), blunt snout bream (Megalobrama amblycephala) and large yellow croaker (Larimichthys crocea)(Reference Dai, Jiang and Yuan4,Reference Jin, Pan and Cheng7,Reference Aloui, Charradi and Hichami9,Reference Wang, Li and Hou15) . It is generally accepted that excess fat deposition is associated with altered tissue lipid metabolism, including lipogenesis and lipolysis. Previous studies demonstrated that fat deposition could be decreased by down-regulating the expression of lipogenesis pathway genes such as sterol regulatory element-binding protein-1(srebp-1), acetyl-CoA carboxylase α (accα) and fatty acid synthase (fas), and/or up-regulation of lipolysis pathway genes such as PPARα (pparα), hormone-sensitive lipase (hsl) and carnitine palmitoyltransferase 1A (cpt1a)(Reference Jin, Lu and Yuan16–Reference Yan, Liao and Wang19). In addition, adiponectin, a hormone involved in the regulation of glucose metabolism and fatty acid breakdown in mammals, could lower intracellular lipid content(Reference Schindler, Pendzialek and Grybel20). Therefore, dietary supplements that can regulate lipid metabolism or adiponectin and, consequently, reduce excess lipid deposition, alleviate hepatic steatosis and attenuate inflammation response would be highly beneficial.
Choline has been shown to be an essential vitamin for fish, playing a vital role in maintaining cell structure and lipid transport in and out of the cells(Reference Blusztajn21,22) . It is well known that choline is a key component of both phosphatidylcholine and acetylcholine, a neurotransmitter(Reference Li, Zhang and Xu23). Recent studies reported that dietary choline supplementation affected hepatic transport and lipid deposition in various fish species, which suggested that dietary choline could reduce hepatic lipid content and influence expression of lipid metabolism genes(Reference Li, Zhang and Xu23–Reference Qin, Dong and Tan26). Moreover, previous studies demonstrated that dietary choline could modulate immune responses by reducing expression of pro-inflammatory biomarkers such as TNF-α (tnfα), IL-1β (il-1β) and NFκB (nfκb), and up-regulating mRNA expression of anti-inflammatory cytokine IL-10 (il-10) and transforming growth factor β-1 (tgfβ-1) in vertebrates including fish(Reference Koca, Bahcecioglu and Poyrazoglu27–Reference Zhao, Jiang and Liu29). However, there are few studies investigating the possible mechanisms whereby dietary choline affects lipid metabolism and subsequently reduces inflammatory response.
Lipopolysaccharide (LPS) is a structural component of the outer membrane of Gram-negative bacteria and one of the most effective stimulators of the immune system, and has been widely used as an experimental model for bacterial infection in animals(Reference Dai, Jiang and Yuan4,Reference Wu, Jiang and Jiang28,Reference Lee, Park and Kim30–Reference Wyns, Plessers and De Backer33) . Furthermore, the LPS inflammation model has been commonly used to evaluate acute-phase responses and the release of pro-inflammatory cytokines through the activation of nfκb (Reference Dai, Jiang and Yuan4,Reference Plessers, Wyns and Watteyn34) . NFκB is a transcription factor belonging to the ‘Rel’ family that represents a crucial intracellular signal transduction system involved in several inflammatory responses, through interaction with the inhibitory κB (IκB) proteins(Reference Pamukcu, Lip and Shantsila35). Activation of NFκB promotes the expression of inflammatory molecules, such as IL-6, IL-8 and TNFα(Reference Öberg, Haseeb and Ahnfelt36). Hence, NFκB is a key nuclear transcription factor tightly linked to the inflammatory response.
Black seabream (A. schlegelii) is a very popular and commercially important marine fish species cultured in China, Japan, Korea and other countries in Southeast Asia, and has been regarded as an excellent aquaculture species for intensive culture since it exhibits rapid growth, high disease resistance, and can tolerate a wide range of environmental conditions(Reference Jin, Pan and Cheng7). Besides, black seabream is a validated experimental model for HFD-induced inflammation as confirmed previously(Reference Jin, Pan and Cheng7). The production of high-quality fish for human consumption requires healthy fish and, therefore, improving fish health is a priority in aquaculture. In the present study, we aimed to investigate how HFD can affect lipid metabolism and cause inflammation by exploring the impacts of dietary choline, supplemented to HFD, as a mechanism to attenuate HFD-induced inflammatory responses.
Materials and methods
Ethics statement
Animal experimentation within the present study was conducted in accordance with the Animal Research Institute Committee guidelines of Ningbo University, China and approved by the Committee of the Animal Research Institute, Ningbo University, China.
Experimental design and diet preparation
Five isonitrogenous (about 42 % crude protein) experimental diets with two levels of lipid (about 11 % and about 17 % crude lipid) were formulated with the diets containing the higher lipid level supplemented with graded levels of choline (Sinopharm Chemical Reagent Co., Ltd). The diets were termed: control, low-fat diet; HFD, high-fat diet; HFD + C1, HFD plus choline (3 g/kg dry diet); HFD + C2, HFD plus choline (6 g/kg dry diet); HFD + C3, HFD plus choline (12 g/kg dry diet) (Table 1). Fishmeal, soyabean protein concentrate, soyabean meal and wheat flour were used as protein sources, with fish oil, palmitic acid and soyabean lecithin used as the main lipid sources. All ingredients were purchased from Ningbo Tech-Bank Feed Co. Ltd. The experimental diets were produced according to the method described in detail previously(Reference Jin, Pan and Cheng7). Briefly, the ground ingredients were mixed in a Hobart type mixer and cold-extruded pellets produced (F-26; Machine Factory of South China University of Technology) with pellet strands cut into uniform sizes (2 and 4 mm diameter pellets) (G-250; Machine Factory of South China University of Technology). Pellets were steamed for 30 min at 90°C, and then air-dried to approximately 10 % moisture, sealed in vacuum-packed bags and stored at −20°C until used in the feeding trial.
HFD, high-fat diet; HFD + C1, HFD + choline (3 g/kg); HFD + C2, HFD + choline (6 g/kg); HFD + C3, HFD + choline (12 g/kg).
* The vitamin premix and mineral mixture were purchased from Ningbo Tech-Bank Feed Co. Ltd.
Feeding trial and experimental conditions
Juvenile black seabream (initial weight 8·16 ± 0·01 g) were obtained from a local commercial hatchery at Xiangshan Bay, Ningbo, China. Prior to the experiment, the black seabream juveniles were acclimatised for 2 weeks and fed with a commercial diet (45 % dietary protein, 12 % crude lipid; Ningbo Tech-Bank Corp.). A completely randomised trial design was implemented. Briefly, a total of 450 black seabream juveniles were randomly allocated to fifteen floating net cages (1·5 m × 1·5 m × 2·0 m) corresponding to triplicate cages of the five dietary treatments. Fish were hand-fed to apparent satiation twice daily at 07.00 and 17.00 hours over 8 weeks. During the experimental period, physico-chemical conditions including temperature (26·6–30·7°C), salinity (25·53–27·86 ‰), dissolved O2 (4·7–6·8 mg/l) and pH (8·0–8·1 mg/l) were monitored daily (YSI Proplus; YSI).
Sample collection
At the end of the feeding trial, fish were sampled 24 h after the last feed, with all fish (other than six fish used for the LPS challenge test) anaesthetised with tricaine methane sulfonate (MS-222). All fish in each cage were weighed and counted to determine weight gain, specific growth rate, feed efficiency and survival. Five fish from each cage (fifteen per treatment) were pooled (n 3) and used for proximate composition of the whole body. Liver samples were collected and pooled from a further three fish per cage (n 3) and stored at −80°C prior to analysis of adiponectin, TAG and cholesterol content. Liver and intestine samples were also rapidly collected from five fish in each cage and stored at −80°C prior to analysis of gene expression (pools of five fish per cage, n 3). The liver was collected from one fish per cage into 4 % paraformaldehyde for histological analysis. Blood samples were taken from the caudal vein of eight fish per cage using 1·5 ml syringes.
Proximate composition analysis
Crude protein, crude lipid, moisture and ash contents of diets as well as the lipid content of whole fish, muscle and liver were determined according to the methods of the Association of Official Analytical Chemists(37). Briefly, crude protein content was determined via the Dumas combustion method with a protein analyser (FP-528; Leco). Moisture was determined by drying the samples to a constant weight at 105°C. Crude lipid contents were determined by Soxhlet extraction using diethyl ether (Soxtec System HT6; Tecator). Ash contents were determined using a muffle furnace at 550°C for 8 h.
Assay of serum and hepatic biochemical indices
Blood was assayed within 24 h of collection after storage at 4°C, with serum collected by centrifugation at 956 g for 10 min at 4°C. Serum biochemical indices including total protein, albumin, TAG, cholesterol, glucose contents and the activities of alkaline phosphatase, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were measured by automatic biochemical analyser (Selectra Pro-M 13-7476) according to the manufacturer's instructions (Nanjing Jiancheng Bioengineering Institute).
Liver samples were homogenised in nine volumes (w/v) of ice-cold physiological saline (0·89 %; w/v), and then centrifuged as above. The contents of adiponectin (Shanghai Jiancheng Bioengineering Institute), TAG and cholesterol (Nanjing Qiaodu Biotechnology Co., Ltd) were assayed using commercial kits according to the manufacturer's instructions by Multiskan spectrum (Thermo).
Histological analysis of liver
Fresh liver tissue was fixed with 4 % paraformaldehyde before paraffin sections were prepared (Servicebio). Briefly, after fixation for at least 24 h, tissue samples were trimmed appropriately in a fume hood before being dehydrated in ethanol with concentration increasing incrementally from 75 % to 100 %. Liver samples were then embedded in paraffin and sliced into sections of 4 µm using a microtome. They were stained with haematoxylin and eosin and images were acquired under a microscope (Nikon Eclipse CI).
Total RNA extraction, reverse transcription and real-time PCR
Gene expression was determined by reverse-transcriptase quantitative PCR (qPCR) as follows. Total RNA was extracted from tissues (liver, intestine and kidney) of juvenile black seabream using Trizol reagent (Takara) according to the manufacturer's instructions. Quantity and quality of isolated RNA were determined spectrophotometrically (Nanodrop 2000; Thermo Fisher Scientific) and on a 1·2 % denaturing agarose gel, respectively. The cDNA was prepared from 1000 ng of DNAase-treated RNA and synthesised using a PrimeScript™ RT Reagent Kit with gDNA Eraser (Perfect Real Time; Takara). The housekeeping gene β-actin was used as the reference gene after confirming its stability across the experimental treatments. Specific primers for the candidate genes nfκb, il-1β, tnfα, tgfβ-1, il-10, accα, fas, srebp-1, lpl, cpt1a, hsl and pparα used for qPCR were designed by Primer Premier 5.0 (Table 2). Amplification was performed using a quantitative thermal cycler (Lightcycler 96; Roche). The qPCR assays were performed in a total volume of 20 µl, containing 1·0 µl of each primer, 10 µl of 2× conc. SYBR Green I Master (Roche), 2 µl of 1/5 diluted cDNA and 6 µl diethyl pyrocarbonate (DEPC)-water. The thermal-cycling conditions used for qPCR were as follows: 95°C for 2 min, followed by forty-five cycles of 95°C for 10 s, 58°C for 10 s and 72°C for 20 s. Standard curves were generated using six different dilutions (in triplicate) of the cDNA samples, and the amplification efficiency was analysed using the equation E = 10(−1/slope)−1(Reference Jothikumar, Cromeans and Robertson40). The amplification efficiencies of all genes were approximately equal and ranged from 87 to 109 %. All gene expression data were presented relative to the expression of the control group (reference group). The expression levels of the target genes were calculated using the 2 method as described by Livak & Schmittgen(Reference Livak and Schmittgen41).
tgfβ-1, Transforming growth factor β-1; accα, acetyl-CoA carboxylase α; fas, fatty acid synthase; srebp-1, sterol regulatory element-binding protein-1; cpt1a, carnitine palmitoyltransferase 1a; hsl, hormone-sensitive lipase.
Lipopolysaccharide injection and sampling
After the 8-week feeding trial, six fish in each cage were randomly collected for LPS challenge to intensify inflammatory responses. LPS (Escherichia coli 055:B5; Sigma-Aldrich) was dissolved in sterile PBS (pH = 7·4) to a final concentration of 0·5 mg/ml. Fish from the HFD, HFD + C1, HFD + C2 and HFD + C3 treatments were individually injected intraperitoneally with 0·2 ml LPS at a dose of 2·5 mg/kg body weight. As control, fish were injected individually with the same volume of sterile PBS. Liver, intestine and kidney were collected from all fish 24 h after injection (samples were pooled per cage; n 3 per dietary treatment), and snap-frozen in liquid N2 and stored at −80°C for later gene expression analysis of nfκb, il-1β, tnfα, tgfβ-1 and il-10 (Reference Dai, Jiang and Yuan4,Reference Wei, Yin and Feng31,Reference Jiang, Yin and Li42,Reference Kumar and Joy43) .
Statistical analysis
Results are presented as means with their standard errors (number of replicates as indicated). The relative gene expression results (qPCR analyses) were expressed as mean normalised ratios corresponding to the ratio between the copy number of the target gene and the copy number of the reference gene, β-actin. The homogeneity of variances (Levene's test) were checked prior to ANOVA followed by Tukey's honestly significant difference test at a significance level of P ≤ 0·05 (IBM SPSS Statistics 20).
Results
Growth performance, feed utilisation, survival and lipid content
In the present study, no statistical differences were found in final body weight, weight gain, specific growth rate, feed efficiency or survival among the five groups (P > 0·05) (Table 3). However, fish fed with the HFD had significantly higher lipid content in whole body and muscle compared with the control group (P < 0·05). Furthermore, compared with the HFD treatment, the lipid content in muscle was significantly reduced by dietary choline supplementation (P < 0·05), and significantly lower lipid content in whole body was recorded in fish fed HFD + C1, but liver lipid content was not significantly affected (P > 0·05) (Fig. 1).
HFD, high-fat diet; HFD + C1, HFD + choline (3 g/kg); HFD + C2, HFD + choline (6 g/kg); HFD + C3, HFD + choline (12 g/kg); IBW, initial body weight; FBW, final body weight; WG, weight gain; SGR, specific growth ratio; FE, feed efficiency.
* WG (%) = 100 × ((final body weight − initial body weight)/initial body weight).
† SGR (%/d) = 100 × ((Ln final body weight (g) − Ln initial body weight) (g)/d).
‡ FE = weight gain (g, wet weight)/feed consumed (g, dry weight).
§ Survival (%) = 100 × (final fish number/initial fish number).
Serum and hepatic biochemical indices
In serum, the activities of AST and ALT were significantly higher in fish fed the HFD than in fish fed the other diets (P < 0·05), and dietary choline supplementation significantly decreased AST and ALT activities in fish fed the HFD (P < 0·05) (Fig. 2(A)). In contrast, no significant differences were found in serum TAG and cholesterol contents among all treatments (P > 0·05) (Fig. 2(B)). In liver, the cholesterol concentration was significantly higher in fish fed the HFD than in the control group, but was reduced in fish fed diets HFD + C1, HFD + C2 and HFD + C3 (P < 0·05). Contrasting results were found for hepatic adiponectin, with significantly lower concentration recorded in fish fed the HFD compared with the control group (P < 0·05), and there was a clear trend for dietary choline to increase adiponectin compared with the HFD group, although no statistical differences were found (P > 0·05) (Fig. 3).
Hepatic histological analysis
In fish fed the control diet, hepatocyte shape and structure were regular and normal, the nucleus with nucleolus was spherical, and basically in the middle of cells (Fig. 4(A)). In fish fed the HFD, hepatocyte nucleoli were vacuolar and had mostly disappeared, the nucleus and other organelles had lysed and liquefied to form large cysts, and cells contained many large vacuolar fat drops (Fig. 4(B)). In fish fed HFD + C1, HFD + C2 and HFD + C3, the shapes of some cells were regular and parts of the cell structure remained normal, some of the nuclei with nucleoli were spherical, and vacuolar fat drops fewer and smaller compared with the HFD group, suggesting that dietary choline prevented or reduced the cell damage caused by the HFD (Fig. 4(C)–(E)).
Lipogenesis and lipolysis pathway key markers
The hepatic expression of cpt1a was significantly up-regulated in fish fed the diets supplemented with choline supplementation compared with fish fed the HFD (P < 0·05). Similarly, hsl expression was significantly up-regulated in fish fed HFD + C3 compared with the HFD group (Fig. 5(A)). On the contrary, the hepatic expression levels of srebp-1 and accα were significantly lower in fish fed the choline-supplemented diets compared with fish fed the HFD (P < 0·05) (Fig. 5(B)).
Inflammatory markers after 8-week feeding trial
The expression levels of genes of the inflammatory response including nuclear transcription factor nfκb, pro-inflammatory cytokines il-1β and tnfα as well as anti-inflammatory cytokine tgfβ-1 and il-10 in liver and intestine are shown in Figs 6 and 7, respectively. In liver and intestine, the expression levels of nfκb and il-1β were significantly up-regulated in fish fed the HFD, and down-regulated in fish fed the diets supplemented with choline (P < 0·05). In contrast, no significant differences were found in tnfα mRNA expression (P > 0·05). The expression levels of tgfβ-1 and il-10 in liver and intestine were generally significantly up-regulated in fish fed the HFD with choline supplementation (P < 0·05), other than hepatic tgfβ-1 mRNA expression, which was not statistically different (P > 0·05).
Inflammatory markers after lipopolysaccharide injection
The expression levels of genes of the inflammatory response including nuclear transcription factor nfκb, pro-inflammatory cytokines il-1β and tnfα as well as anti-inflammatory cytokine tgfβ-1 and il-10 in liver, intestine and kidney of juvenile black seabream after LPS injection are presented in Figs 8–10, respectively. In all three tissues, the expression levels of nfκb were significantly higher in fish fed the HFD compared with fish fed the other diets, and down-regulated in fish fed the diets supplemented with choline (P < 0·05). Similarly, the pro-inflammatory cytokines il-1β and tnfα were decreased by dietary choline supplementation compared with fish fed the HFD (P < 0·05), although some differences were not statistically significant (P > 0·05). In contrast, expression levels of the anti-inflammatory cytokine il-10 in liver and kidney were significantly lower in fish fed the HFD, and significantly up-regulated by choline supplementation (P < 0·05). However, although there was a trend of increasing expression of il-10 in intestine in diets supplemented with choline, this was not significant (P > 0·05). Similar results were also recorded for tgfβ-1 expression in liver, intestine and kidney, with expressions tending to increase in fish fed the choline-supplemented diets (HFD + C1, HFD + C2 and HFD + C3), but not statistically significant (P > 0·05).
Discussion
Previous studies have demonstrated that choline is a vitamin for young vertebrates, it is the most abundant vitamin constituent in most fish feeds, and it can provide active methyl groups, which can participate in the anabolism of important physiological compounds such as methionine, phospholipids and carnitine(22,Reference Li, Li and Xu24,Reference Luo, Wei and Ye25,Reference Wu, Jiang and Jiang28,Reference Zhao, Jiang and Liu29,Reference Halver, Halver and Hardy44–Reference Jiang, Wang and Liu46) . Recent studies showed that adequate dietary supplementation of choline could improve growth performance and feed utilisation in various fish species(Reference Li, Li and Xu24,Reference Luo, Wei and Ye25,Reference Mai, Xiao and Ai45–Reference Wu, Feng and Kuang47) . In addition, weight gain increased significantly with increasing dietary choline supplementation when dietary lipid level was 11 %, and additional choline supplementation improved growth performance of M. amblycephala fed a HFD (15 % lipid)(Reference Li, Zhang and Xu23,Reference Li, Li and Xu24) . However, in the present study, graded levels of dietary choline (3, 6 or 12 g/kg) did not significantly affect the growth performance or feed utilisation of black seabream fed a HFD. The contrasting results could be explained by the higher dietary lipid level (16·5%) used in the present study. Additionally, it might be related to the duration of the trial, which was only 8 weeks in the present study. The impact of a HFD on growth was shown previously to be time-dependent in M. amblycephala (Reference Dai, Jiang and Yuan4). Furthermore, few studies have been conducted on the effects of dietary choline in fish fed HFD. However, although growth performance and feed utilisation in black seabream were not affected by HFD supplemented with choline, the present study revealed that dietary choline had impacts on lipid deposition, lipid metabolism and inflammation response that gave insights to possible regulatory mechanisms.
AST and ALT are two important aminotransferases in fish that are often used as general indicators of vertebrate liver function(Reference Li, Zhang and Xu23,Reference Yamamoto and Egami48) . General cellular damage occurring in hepatic steatosis and injury in mammals is usually monitored by analysing leakage of cellular enzymes like AST and ALT into the blood(Reference Cheng and Kong49,Reference Takeuchi-Yorimoto, Noto and Yamada50) , and similar mechanisms have also been confirmed in some fish species(Reference Li, Zhang and Xu23,Reference Zhou, Shao and Xu51,Reference Zhou, Jin and Elmada52) . Significantly increased AST and ALT activities in serum were observed in fish fed diet HFD, consistent with a previous study in M. amblycephala fed HFD(Reference Li, Zhang and Xu23). This suggested that there was a release of intracellular enzymes into the blood, indicating that possible damage to hepatocytes was induced by feeding HFD to black seabream. However, AST and ALT activities were reduced with increasing dietary choline in fish fed the HFD in the present study, demonstrating that dietary choline supplementation could mitigate the damage induced by a HFD in black seabream. Cholesterol and TAG levels in serum were unaffected by diet, whereas hepatic cholesterol and TAG concentrations were increased in fish fed the HFD, and decreased with choline supplementation, which was similar to results obtained in a previous study in Nile tilapia (Oreochromis niloticus)(Reference He, Ning and Chen6). In addition, adiponectin plays a crucial role in hepatic lipid metabolism, with the beneficial effects of adiponectin in mammals being partially attributed to increased fatty acid oxidation in tissues such as liver and muscle(Reference Chen, Zhang and Li53). In the present study, levels of adiponectin in liver were lowest in fish fed the HFD, and its level showed an increasing trend with dietary choline supplementation. This may indicate that choline supplementation to HFD treatments could reduce the risk of fat accumulation and hepatic steatosis in black seabream by reducing hepatic cholesterol and TAG, and restoring adiponectin concentration.
Choline has attracted attention as an important active substance in the body. Previous studies have confirmed that choline can act as an ‘anti-fatty liver' factor by preventing or reducing lipid deposition in the liver. Subsequently, numerous studies on choline have been carried out to further explore the mechanism of choline's anti-fatty liver effect, and provide insight into its important role in nutrient metabolism and regulation(Reference Li, Zhang and Xu23–Reference Qin, Dong and Tan26,Reference Halver, Halver and Hardy44,Reference Mai, Xiao and Ai45) . In the present study, the highest lipid contents in whole body and muscle were recorded in fish fed the HFD compared with fish fed the other diets, and muscle lipid contents were reduced in fish fed the HFD treatments supplemented with choline. Similar results have been reported previously in various fish species, confirming that dietary choline could reduce lipid content of fish(Reference Li, Zhang and Xu23–Reference Qin, Dong and Tan26,Reference Mai, Xiao and Ai45) . The mechanism of dietary choline supplementation on lipid deposition caused by the HFD was further studied by investigating histopathological changes. The results indicated the damage that feeding a HFD could cause in the liver of black seabream, with the nucleus and other organelles lysed, forming large cysts, and the presence of many large vacuolar fat drops in hepatocytes, similar to results reported previously in mice(Reference Su, Chang and Chou54,Reference Wang, Yang and Ji55) . The present study indicated that dietary choline could prevent this damage to the liver and/or promote almost complete recovery. These findings confirmed results from other fish species that demonstrated inverse correlations between dietary choline levels and hepatic lipid contents(Reference Li, Zhang and Xu23,Reference Li, Li and Xu24,Reference Jiang, Wang and Liu46) .
To further explore the lipid-lowering mechanism of dietary choline, we herein analysed the relative expression of some hepatic genes involved in lipolysis (pparα, cpt1a and hsl) and lipogenesis (srepb-1, fas, and accα) pathways. It is believed that PPARα can promote fatty acid β-oxidation, and modulate expression of genes encoding several mitochondrial fatty acid-catabolising enzymes(Reference Aoyama, Peters and Iritani56 ), CPT1 is regarded as the main regulatory enzyme in fatty acid oxidation catalysing the conversion of cytosolic fatty acyl-CoA to fatty acyl-carnitine for entry into mitochondria(Reference Kerner and Hoppel57,Reference Yang58) , and HSL is an important enzyme involved in lipolysis(Reference Ma, Shao and Xu59). The present study indicated that, in fish fed HFD supplemented with choline, cpt1a and hsl expression levels were up-regulated compared with fish fed the HFD. This demonstrated that dietary choline could promote lipolysis and fatty acid β-oxidation by up-regulating key genes in these pathways. Moreover, FAS can catalyse de novo fatty acid synthesis(Reference Cowey and Walton60), SREBP-1 is a major regulator of fatty acid and lipid biosynthesis(Reference Minghetti, Leaver and Tocher61), and ACCα is a cytosolic enzyme that controls the production of malonyl-CoA and thus plays an important role in the biosynthesis of long-chain fatty acids(Reference Takai, Saito and Yamamoto62–Reference Qian, Li and Zhang64). In the present study, the expression levels of srebp-1 and accα showed a downward trend in the liver of fish fed the choline-supplemented diets. These results were consistent with previous studies in A. schlegelii, Pseudosciaena crocea and O. niloticus (Reference He, Ning and Chen6,Reference Jin, Pan and Cheng7,Reference Wang, Li and Hou15) . Hence, we conclude that dietary choline supplementation can reduce lipid deposition and alleviate hepatic steatosis through the regulation of lipid metabolism by up-regulating lipolysis and down-regulating lipogenesis pathway gene expression levels.
Previous studies revealed that HFD-induced lipid accumulation in the liver probably causes endoplasmic reticulum stress and accelerates the release of cytokines, thereby inducing inflammation(Reference Su, Chang and Chou54,Reference Barbuio, Milanski and Bertolo65–Reference Varga, Czimmerer and Nagy67) , which was confirmed in our previous study(Reference Jin, Pan and Cheng7). The nuclear transcription factor nfκb is a key upstream signalling molecule and when NF-κB is activated, it transfers into the nucleus and induces the expression of multiple inflammatory makers, including tnf-α and il-1β (Reference Wang, Yang and Ji55,Reference Dong, Jiang and Liu68) . In the present study, the transcript expression levels of nuclear transcription factor nfκb was up-regulated in fish fed the HFD both in the liver and intestine compared with fish fed the control diet. Consequently, the pro-inflammatory cytokines il-1β and tnfα were also up-regulated in fish fed the HFD without choline supplementation, confirming previous reports in M. amblycephala (Reference Li, Zhang and Xu23). The relative expression levels of nfκb, il-1β and tnfα were all decreased in fish fed the diets with choline supplementation. These results were generally consistent with recent studies, indicating that moderate levels of dietary choline could alleviate inflammation by modulating NF-κB signalling molecules(Reference Qin, Dong and Tan26,Reference Wu, Jiang and Jiang28,Reference Zhao, Jiang and Liu29) . Moreover, tgfβ-1 and il-10 are two common anti-inflammatory cytokines(Reference Wu, Jiang and Jiang28) and they were up-regulated in the liver and intestine by choline supplementation in the present study. Similar results were obtained in other fish species(Reference Wu, Jiang and Jiang28,Reference Zhao, Jiang and Liu29) . Combined, these results indicated that dietary choline supplementation could reduce inflammatory responses. Hence, the present study demonstrated that fish fed the HFD caused lipid deposition, activated NFκB, and pro-inflammatory cytokines were released, thereby causing an inflammatory response. Dietary choline supplementation could attenuate inflammation by modulating NF-κB signalling molecules and increasing expression of anti-inflammation markers.
In order to further verify that dietary choline supplementation has the effect of relieving inflammation, the LPS challenge experiment was conducted to promote a strong inflammation response. In teleosts, it is well known that inflammatory challenges in vivo and in vitro are able to induce the expression of genes of various pro-inflammatory factors with rapid kinetics(Reference Zhang, Chen and Wei69). Recently, it reported that the LPS effect varied depending upon the cytokine, stimulating (il-1β), inhibiting (tgfβ-1) or ineffective (tnf-α)(Reference Kumar and Joy43). In the present study, the highest expression levels of nfκb, il-1β and tnfα in the liver, intestine and kidney were all recorded in fish fed the HFD 24 h after LPS injection, and all were lower in fish fed supplementary dietary choline. On the contrary, after LPS the lowest expression levels of il-10 in the liver and kidney were found in fish fed the HFD, similar to results obtained in other fish species(Reference Dai, Jiang and Yuan4,Reference Wu, Jiang and Jiang28,Reference Lee, Park and Kim30–Reference Wu, Yang and Ansari32) . Likewise, il-10 expression levels were up-regulated by dietary choline supplementation. However, no significant differences were found in tgfβ-1 expression in any tissue, although there was an upward trend. Therefore, the LPS injection experiment generally confirmed that dietary choline supplementation had an effect of relieving inflammation by regulating inflammatory cytokines expression.
Conclusion
In conclusion, the present study provided further insight to the mechanism of the HFD-induced inflammatory response that results in lipid accumulation, hepatic steatosis and NFκB activation (Fig. 11(A)). Furthermore, the present study revealed that dietary choline supplementation attenuated the HFD-induced inflammatory response (Fig. 11(B)). Dietary choline supplementation could increase hepatic adiponectin content and expression of lipolysis pathway genes, and reduce expression of lipogenesis pathway genes, promoting a lipid-lowering effect, and restoring lipid metabolism balance, and reducing hepatic steatosis and, subsequently, attenuating inflammation by modulating NF-κB signalling molecules to suppress pro-inflammatory genes and increasing expression of anti-inflammatory genes.
Acknowledgements
The authors are grateful to all the members in Fish and Shellfish Nutrition Laboratory of Ningbo University, without whose support we could not have finished this study.
This research was supported by the National Natural Science Foundation of China (grant no. 31802303), Natural Science Foundation of Ningbo (grant no. 2018A610343), National Key R & D Program of China (2018YFD0900400), Key Research Program of Zhejiang Province of China (no. 2018C02037), Zhejiang Aquaculture Nutrition & Feed Technology Service Team (ZJANFTST2017-2), the Open Fund of Zhejiang Provincial Top Key Discipline of Aquaculture in Ningbo University and K. C. Wong Magna Fund in Ningbo University.
M. J. and Q. C. Z. conceived and designed the experiments. T. T. P., Y. D. S., T. T. Z. and X. C. performed the experiments. T. T. P. and M. J. analysed the data. M. J. and T. T. P. contributed reagents/materials/analysis tools. T. T. P., M. J., Y. D. S., T. T. Z., X. C. and P. S. prepared the fish diets. T. T. P. conducted the fish feeding trial. T. T. P., M. J., Y. D. S., T. T. Z., X. C., P. S. and L. F. J. collected the samples. M. J., T. T. P., D. R. T., M. B. B. and Ó. M. wrote the paper. All authors contributed to and approved the manuscript.
The authors declare that there are no conflicts of interest.